Skip NavigationSkip to Content

Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes

  1. Author:
    Abraham, E. H.
    Shrivastav, B.
    Salikhova, A. Y.
    Sterling, K. M.
    Johnston, N.
    Guidotti, G.
    Scala, S.
    Litman, T.
    Chan, K. C.
    Arceci, R. J.
    Steiglitz, K.
    Herscher, L.
    Okunieff, P.
  2. Author Address

    Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA. Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA. NCI, Div Clin Sci, Radiat Oncol Branch, Bethesda, MD 20892 USA. NCI, Div Clin Sci, Radiat Oncol Branch, Bethesda, MD 20892 USA. Harvard Univ, Dept Biochem & Mol Biol, Cambridge, MA 02138 USA. NCI, Div Clin Sci, Bethesda, MD 20892 USA. NCI, Analyt Chem Lab, SAIC Frederick, Frederick, MD 21702 USA. Harvard Univ, Sch Med, Dana Farber Canc Ctr, Boston, MA 02115 USA. Univ Rochester, Ctr Canc, Dept Radiat Oncol, Rochester, NY 14642 USA. Abraham EH Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA.
    1. Year: 2001
    2. Date: JAN-FEB
  1. Journal: Blood Cells Molecules and Diseases
    1. 27
    2. 1
    3. Pages: 181-200
  2. Type of Article: Article
  1. Abstract:

    P-glycoprotein is involved with the removal of drugs, most of them cations, from the plasma membrane and cytoplasm. Pgp is also associated with movement of ATP, an anion, from the cytoplasm to the extracellular space. The central question of this study is whether drug and ATP transport associated with the expression of Pgp are in any way coupled. We have measured the stoichiometry of transport coupling between drug and ATP release. The drug and ATP transport that is inhibitable by the sulfonylurea compound, glyburide (P. E. Golstein, A. Boom, J. van Geffel, P. Jacobs, B. Masereel, and R. Beauwens, Pfluger's Arch. 437, 652, 1999), permits determination of the transport coupling ratio, which is close to 1:1. In view of this result, we asked whether ATP interacts directly with Pgp substrates. We show by measuring the movement of Pgp substrates in electric fields that ATP and drug movement are coupled. The results are compatible with the view that substrates for Pgp efflux are driven by the movement of ATP through electrostatic interaction and effective ATP-drug complex formation with net anionic character. This mechanism not only pertains to drug efflux from tumor cells overexpressing Pgp, but also provides a framework for understanding the role of erythrocytes in drug resistance. The erythrocyte consists of a membrane surrounding a millimolar pool of ATP. Mammalian RBCs have no nucleus or DNA drug/toxin targets. From the perspective of drug/ATP complex formation, the RBC serves as an important electrochemical sink for toxins. The presence in the erythrocyte membrane of approximately 100 Pgp copies per RBC provides a mechanism for eventual toxin clearance. The RBC transport of toxins permits their removal from sensitive structures and ultimate clearance from the organism via the liver and/or kidneys. (C) 2001 Academic Press.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel